Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Formation Bio, a biotech accelerator, has successfully raised $380 million for a new fund to support early stage biotech companies through clinical trials. Additionally, Formation Bio has secured $372 million in a Series D funding round to boost drug development with AI, focusing on in-licensing 10-15 drugs over the next 5 years.
Formation Bio, which uses AI to co-develops drugs with biotech and pharma companies, raised a $372M Series D led by a16z, bringing its total funding to $528M (@kyle_l_wiggers / TechCrunch) https://t.co/79oeYlBVpI 📫 Subscribe: https://t.co/OyWeKSRpIM https://t.co/Ua6VrusQM2
We are excited to lead the latest round in @formationbio, an AI-native pharma company going after the major bottleneck in drug development through a best-in-class team, novel platform, and stellar partnerships. The company has already built capabilities and expertise within the…
Formation Bio raises $372M to boost drug development with AI: https://t.co/waMJ0yj55H by TechCrunch #infosec #cybersecurity #technology #news
